questionsmedicales.fr
Facteurs biologiques
Pigments biologiques
Porphyrines
Porphyrines : Questions médicales fréquentes
Termes MeSH sélectionnés :
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Porphyrines : Questions médicales les plus fréquentes",
"headline": "Porphyrines : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Porphyrines : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-03-04",
"dateModified": "2025-02-27",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Porphyrines"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Pigments biologiques",
"url": "https://questionsmedicales.fr/mesh/D010860",
"about": {
"@type": "MedicalCondition",
"name": "Pigments biologiques",
"code": {
"@type": "MedicalCode",
"code": "D010860",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D23.767"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Coproporphyrines",
"alternateName": "Coproporphyrins",
"url": "https://questionsmedicales.fr/mesh/D003306",
"about": {
"@type": "MedicalCondition",
"name": "Coproporphyrines",
"code": {
"@type": "MedicalCode",
"code": "D003306",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D23.767.727.250"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Deutéroporphyrines",
"alternateName": "Deuteroporphyrins",
"url": "https://questionsmedicales.fr/mesh/D003905",
"about": {
"@type": "MedicalCondition",
"name": "Deutéroporphyrines",
"code": {
"@type": "MedicalCode",
"code": "D003905",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D23.767.727.280"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Étioporphyrines",
"alternateName": "Etioporphyrins",
"url": "https://questionsmedicales.fr/mesh/D005044",
"about": {
"@type": "MedicalCondition",
"name": "Étioporphyrines",
"code": {
"@type": "MedicalCode",
"code": "D005044",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D23.767.727.340"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Hématoporphyrines",
"alternateName": "Hematoporphyrins",
"url": "https://questionsmedicales.fr/mesh/D006415",
"about": {
"@type": "MedicalCondition",
"name": "Hématoporphyrines",
"code": {
"@type": "MedicalCode",
"code": "D006415",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D23.767.727.462"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Hématoporphyrine D",
"alternateName": "Hematoporphyrin Derivative",
"url": "https://questionsmedicales.fr/mesh/D017324",
"about": {
"@type": "MedicalCondition",
"name": "Hématoporphyrine D",
"code": {
"@type": "MedicalCode",
"code": "D017324",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D23.767.727.462.400"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Éther de dihématoporphyrine",
"alternateName": "Dihematoporphyrin Ether",
"url": "https://questionsmedicales.fr/mesh/D017323",
"about": {
"@type": "MedicalCondition",
"name": "Éther de dihématoporphyrine",
"code": {
"@type": "MedicalCode",
"code": "D017323",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D23.767.727.462.400.200"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Éther de dihématoporphyrine",
"alternateName": "Dihematoporphyrin Ether",
"url": "https://questionsmedicales.fr/mesh/D017323",
"about": {
"@type": "MedicalCondition",
"name": "Éther de dihématoporphyrine",
"code": {
"@type": "MedicalCode",
"code": "D017323",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D23.767.727.462.400.200"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Mésoporphyrines",
"alternateName": "Mesoporphyrins",
"url": "https://questionsmedicales.fr/mesh/D008652",
"about": {
"@type": "MedicalCondition",
"name": "Mésoporphyrines",
"code": {
"@type": "MedicalCode",
"code": "D008652",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D23.767.727.620"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Métalloporphyrines",
"alternateName": "Metalloporphyrins",
"url": "https://questionsmedicales.fr/mesh/D008665",
"about": {
"@type": "MedicalCondition",
"name": "Métalloporphyrines",
"code": {
"@type": "MedicalCode",
"code": "D008665",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D23.767.727.640"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Hème",
"alternateName": "Heme",
"url": "https://questionsmedicales.fr/mesh/D006418",
"about": {
"@type": "MedicalCondition",
"name": "Hème",
"code": {
"@type": "MedicalCode",
"code": "D006418",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D23.767.727.640.587"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Hémine",
"alternateName": "Hemin",
"url": "https://questionsmedicales.fr/mesh/D006427",
"about": {
"@type": "MedicalCondition",
"name": "Hémine",
"code": {
"@type": "MedicalCode",
"code": "D006427",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D23.767.727.640.587.462"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Hémine",
"alternateName": "Hemin",
"url": "https://questionsmedicales.fr/mesh/D006427",
"about": {
"@type": "MedicalCondition",
"name": "Hémine",
"code": {
"@type": "MedicalCode",
"code": "D006427",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D23.767.727.640.587.462"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Protoporphyrines",
"alternateName": "Protoporphyrins",
"url": "https://questionsmedicales.fr/mesh/D011524",
"about": {
"@type": "MedicalCondition",
"name": "Protoporphyrines",
"code": {
"@type": "MedicalCode",
"code": "D011524",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D23.767.727.725"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Uroporphyrines",
"alternateName": "Uroporphyrins",
"url": "https://questionsmedicales.fr/mesh/D014578",
"about": {
"@type": "MedicalCondition",
"name": "Uroporphyrines",
"code": {
"@type": "MedicalCode",
"code": "D014578",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D23.767.727.880"
}
}
}
],
"about": {
"@type": "MedicalCondition",
"name": "Porphyrines",
"alternateName": "Porphyrins",
"code": {
"@type": "MedicalCode",
"code": "D011166",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Harry L Anderson",
"url": "https://questionsmedicales.fr/author/Harry%20L%20Anderson",
"affiliation": {
"@type": "Organization",
"name": "Department of Chemistry, University of Oxford, Chemistry Research Laboratory, OX1 3TA, Oxford, UK."
}
},
{
"@type": "Person",
"name": "Donato Monti",
"url": "https://questionsmedicales.fr/author/Donato%20Monti",
"affiliation": {
"@type": "Organization",
"name": "Department of Chemistry, Sapienza, University of Rome Piazzale Aldo Moro 5 00185 Rome Italy."
}
},
{
"@type": "Person",
"name": "Manuela Stefanelli",
"url": "https://questionsmedicales.fr/author/Manuela%20Stefanelli",
"affiliation": {
"@type": "Organization",
"name": "Department of Chemical Science and Technologies, University of Rome Tor Vergata via della Ricerca Scientifica 1 00133 Rome Italy gabriele.magna@uniroma2.it."
}
},
{
"@type": "Person",
"name": "Gabriele Magna",
"url": "https://questionsmedicales.fr/author/Gabriele%20Magna",
"affiliation": {
"@type": "Organization",
"name": "Department of Chemical Science and Technologies, University of Rome Tor Vergata via della Ricerca Scientifica 1 00133 Rome Italy gabriele.magna@uniroma2.it."
}
},
{
"@type": "Person",
"name": "Roberto Paolesse",
"url": "https://questionsmedicales.fr/author/Roberto%20Paolesse",
"affiliation": {
"@type": "Organization",
"name": "Department of Chemical Science and Technologies, University of Rome Tor Vergata via della Ricerca Scientifica 1 00133 Rome Italy gabriele.magna@uniroma2.it."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "LFP polarity changes across cortical and eccentricity in primary visual cortex.",
"datePublished": "2023-02-27",
"url": "https://questionsmedicales.fr/article/36922925",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3389/fnins.2023.1138602"
}
},
{
"@type": "ScholarlyArticle",
"name": "Characterization of extracellular spike waveforms recorded in wallaby primary visual cortex.",
"datePublished": "2023-09-08",
"url": "https://questionsmedicales.fr/article/37746137",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3389/fnins.2023.1244952"
}
},
{
"@type": "ScholarlyArticle",
"name": "Cortical depth profiles in primary visual cortex for illusory and imaginary experiences.",
"datePublished": "2024-02-02",
"url": "https://questionsmedicales.fr/article/38307834",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1038/s41467-024-45065-w"
}
},
{
"@type": "ScholarlyArticle",
"name": "Altered dynamic functional connectivity in the primary visual cortex in patients with primary angle-closure glaucoma.",
"datePublished": "2023-02-02",
"url": "https://questionsmedicales.fr/article/36816121",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3389/fnins.2023.1131247"
}
},
{
"@type": "ScholarlyArticle",
"name": "Visual experience reduces the spatial redundancy between cortical feedback inputs and primary visual cortex neurons.",
"datePublished": "2024-08-01",
"url": "https://questionsmedicales.fr/article/39137776",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.neuron.2024.07.009"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Facteurs biologiques",
"item": "https://questionsmedicales.fr/mesh/D001685"
},
{
"@type": "ListItem",
"position": 3,
"name": "Pigments biologiques",
"item": "https://questionsmedicales.fr/mesh/D010860"
},
{
"@type": "ListItem",
"position": 4,
"name": "Porphyrines",
"item": "https://questionsmedicales.fr/mesh/D011166"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Porphyrines - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Porphyrines",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-16",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Porphyrines",
"description": "Comment diagnostiquer une porphyrie ?\nQuels tests sont utilisés pour les porphyrines ?\nQuels symptômes indiquent une porphyrie ?\nLes tests génétiques sont-ils nécessaires ?\nComment interpréter les résultats des tests ?",
"url": "https://questionsmedicales.fr/mesh/D011166?mesh_terms=Primary+Visual+Cortex&page=5#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Porphyrines",
"description": "Quels sont les symptômes courants des porphyries ?\nLes porphyries causent-elles des douleurs ?\nY a-t-il des symptômes cutanés ?\nLes porphyries affectent-elles le système nerveux ?\nLes symptômes varient-ils selon le type de porphyrie ?",
"url": "https://questionsmedicales.fr/mesh/D011166?mesh_terms=Primary+Visual+Cortex&page=5#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Porphyrines",
"description": "Comment prévenir les crises de porphyrie ?\nY a-t-il des conseils diététiques pour les patients ?\nLes patients doivent-ils éviter certains médicaments ?\nLa gestion du stress est-elle importante ?\nLes patients doivent-ils être suivis régulièrement ?",
"url": "https://questionsmedicales.fr/mesh/D011166?mesh_terms=Primary+Visual+Cortex&page=5#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Porphyrines",
"description": "Quel est le traitement principal des porphyries ?\nLes transfusions sanguines sont-elles nécessaires ?\nY a-t-il des médicaments spécifiques pour les porphyries ?\nComment gérer les crises de porphyrie ?\nLa photoprotection est-elle recommandée ?",
"url": "https://questionsmedicales.fr/mesh/D011166?mesh_terms=Primary+Visual+Cortex&page=5#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Porphyrines",
"description": "Quelles sont les complications possibles des porphyries ?\nLes porphyries peuvent-elles causer des dommages au foie ?\nY a-t-il un risque accru de cancer ?\nLes complications neurologiques sont-elles fréquentes ?\nComment gérer les complications des porphyries ?",
"url": "https://questionsmedicales.fr/mesh/D011166?mesh_terms=Primary+Visual+Cortex&page=5#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Porphyrines",
"description": "Quels sont les facteurs de risque des porphyries ?\nL'hérédité joue-t-elle un rôle ?\nLes femmes sont-elles plus à risque ?\nL'alcool augmente-t-il le risque ?\nLes infections peuvent-elles aggraver la condition ?",
"url": "https://questionsmedicales.fr/mesh/D011166?mesh_terms=Primary+Visual+Cortex&page=5#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer une porphyrie ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le diagnostic repose sur des tests sanguins et urinaires pour mesurer les niveaux de porphyrines."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour les porphyrines ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les tests incluent l'analyse des urines, du sang et parfois des biopsies de peau."
}
},
{
"@type": "Question",
"name": "Quels symptômes indiquent une porphyrie ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes peuvent inclure des douleurs abdominales, des troubles neurologiques et des photosensibilités."
}
},
{
"@type": "Question",
"name": "Les tests génétiques sont-ils nécessaires ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des tests génétiques peuvent aider à confirmer certains types de porphyries héréditaires."
}
},
{
"@type": "Question",
"name": "Comment interpréter les résultats des tests ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des niveaux élevés de porphyrines dans le sang ou l'urine indiquent une porphyrie."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes courants des porphyries ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent des douleurs abdominales, des éruptions cutanées et des troubles mentaux."
}
},
{
"@type": "Question",
"name": "Les porphyries causent-elles des douleurs ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des douleurs abdominales aiguës sont fréquentes lors des crises de porphyrie."
}
},
{
"@type": "Question",
"name": "Y a-t-il des symptômes cutanés ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des éruptions cutanées et une photosensibilité peuvent survenir, surtout dans la porphyrie cutanée."
}
},
{
"@type": "Question",
"name": "Les porphyries affectent-elles le système nerveux ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elles peuvent provoquer des troubles neurologiques, y compris des crises et des hallucinations."
}
},
{
"@type": "Question",
"name": "Les symptômes varient-ils selon le type de porphyrie ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, chaque type de porphyrie présente des symptômes spécifiques et des manifestations cliniques."
}
},
{
"@type": "Question",
"name": "Comment prévenir les crises de porphyrie ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Éviter les déclencheurs comme certains médicaments, l'alcool et le stress peut aider."
}
},
{
"@type": "Question",
"name": "Y a-t-il des conseils diététiques pour les patients ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une alimentation équilibrée et riche en glucides peut aider à prévenir les crises."
}
},
{
"@type": "Question",
"name": "Les patients doivent-ils éviter certains médicaments ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certains médicaments peuvent déclencher des crises et doivent être évités."
}
},
{
"@type": "Question",
"name": "La gestion du stress est-elle importante ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, la gestion du stress est cruciale pour prévenir les crises de porphyrie."
}
},
{
"@type": "Question",
"name": "Les patients doivent-ils être suivis régulièrement ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, un suivi médical régulier est essentiel pour surveiller l'évolution de la maladie."
}
},
{
"@type": "Question",
"name": "Quel est le traitement principal des porphyries ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le traitement principal inclut l'évitement des déclencheurs et des médicaments pour soulager les symptômes."
}
},
{
"@type": "Question",
"name": "Les transfusions sanguines sont-elles nécessaires ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Dans certains cas, des transfusions peuvent être nécessaires pour traiter l'anémie associée."
}
},
{
"@type": "Question",
"name": "Y a-t-il des médicaments spécifiques pour les porphyries ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des médicaments comme l'hématine peuvent être utilisés pour traiter les crises aiguës de porphyrie."
}
},
{
"@type": "Question",
"name": "Comment gérer les crises de porphyrie ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les crises peuvent être gérées par des soins d'urgence et des traitements symptomatiques."
}
},
{
"@type": "Question",
"name": "La photoprotection est-elle recommandée ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les patients doivent éviter l'exposition au soleil et utiliser des écrans solaires."
}
},
{
"@type": "Question",
"name": "Quelles sont les complications possibles des porphyries ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications incluent des lésions nerveuses, des problèmes hépatiques et des infections."
}
},
{
"@type": "Question",
"name": "Les porphyries peuvent-elles causer des dommages au foie ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certaines porphyries peuvent entraîner des lésions hépatiques graves."
}
},
{
"@type": "Question",
"name": "Y a-t-il un risque accru de cancer ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines porphyries, comme la porphyrie cutanée, peuvent augmenter le risque de cancer de la peau."
}
},
{
"@type": "Question",
"name": "Les complications neurologiques sont-elles fréquentes ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des complications neurologiques peuvent survenir, affectant la qualité de vie."
}
},
{
"@type": "Question",
"name": "Comment gérer les complications des porphyries ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "La gestion des complications nécessite un suivi médical et des traitements adaptés."
}
},
{
"@type": "Question",
"name": "Quels sont les facteurs de risque des porphyries ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les facteurs incluent des antécédents familiaux, certains médicaments et des conditions hépatiques."
}
},
{
"@type": "Question",
"name": "L'hérédité joue-t-elle un rôle ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certaines porphyries sont héréditaires et peuvent être transmises dans les familles."
}
},
{
"@type": "Question",
"name": "Les femmes sont-elles plus à risque ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines études montrent que les femmes peuvent être plus touchées par certaines porphyries."
}
},
{
"@type": "Question",
"name": "L'alcool augmente-t-il le risque ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, la consommation d'alcool peut déclencher des crises chez les personnes prédisposées."
}
},
{
"@type": "Question",
"name": "Les infections peuvent-elles aggraver la condition ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certaines infections peuvent exacerber les symptômes des porphyries."
}
}
]
}
]
}
Local field potentials (LFPs) can evaluate neural population activity in the cortex and their interaction with other cortical areas. Analyzing current source density (CSD) rather than LFPs is very sig...
Extracellular recordings were made from 642 units in the primary visual cortex (V1) of a highly visual marsupial, the Tammar wallaby. The receptive field (RF) characteristics of the cells were objecti...
Visual illusions and mental imagery are non-physical sensory experiences that involve cortical feedback processing in the primary visual cortex. Using laminar functional magnetic resonance imaging (fM...
Glaucoma is the main blindness-causing disease in the world. Previous neuroimaging studies demonstrated that glaucoma not only causes the loss of optic ganglion cells but also leads to the abnormal fu...
A total of 34 patients with PACG (23 men and 11 women) and 34 well-matched healthy controls (HCs) were enrolled in the study. The dynamic functional connectivity (dFC) with the sliding window method w...
Compared with HCs, patients with PACG showed increased dFC values between left V1 and bilateral calcarine (CAL). Meanwhile, patients with PACG showed increased dFC values between right V1 and bilatera...
Our study demonstrated that patients with PACG showed increased dFC within the visual network, which might indicate the increased variability FC in the V1 in patients with PACG....
The role of experience in the organization of cortical feedback (FB) remains unknown. We measured the effects of manipulating visual experience on the retinotopic specificity of supragranular and infr...
Minicolumns are thought to be a fundamental neural unit in the neocortex and their replication may have formed the basis of the rapid cortical expansion that occurred during primate evolution. We soug...
The study of the neural substrates that serve conscious vision is one of the unsolved questions of cognitive neuroscience. So far, consciousness literature has endeavoured to disentangle which brain a...
Repeated stimulus exposure alters the brain's response to the stimulus. We investigated the underlying neural mechanisms by recording functional MRI data from human observers passively viewing 120 pre...
Acetylcholine is a neurotransmitter that plays a variety of roles in the central nervous system. It was previously shown that blocking muscarinic receptors with a non-selective antagonist prevents a f...
Modeling neuron responses to stimuli can shed light on next-generation technologies such as brain-chip interfaces. Furthermore, high-performing models can serve to help formulate hypotheses and reveal...